Dupilumab as treatment of actinic prurigo suggests pathophysiologic mechanism of disease: A case series

JAAD Case Rep. 2024 Feb 29:46:89-91. doi: 10.1016/j.jdcr.2024.01.039. eCollection 2024 Apr.

Catherine S Barker¹, Lauren Sattele², Nicholas Strat³, Sophia Daniel⁴, Alan Snyder⁵, Mark Siegel^{5

6}, Lara Wine Lee^{5

6}

¹ Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina.
² College of Medicine, University of South Carolina, Columbia, South Carolina.
³ College of Medicine, University of South Carolina, Greenville, South Carolina.
⁴ College of Medicine, University of Kentucky, Lexington, Kentucky.
⁵ Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.
⁶ Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.

No abstract available

Keywords: IL-13; IL-4; Th2; actinic prurigo; dupilumab; pharmacology; photosensitivity.

Publication types